Synthesis of new derivatives of 1-[1-(2-pyridyl)-imidazolidine-2-ylidene]-3-aryl(arylakyl)ureas

Authors

  • Elżbieta Szacoń Chair and Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modeling Unit, Faculty of Pharmacy with Medical Analytics Division, Medical University of Lublin, Poland Author
  • Marzena Rządkowska Chair and Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modeling Unit, Faculty of Pharmacy with Medical Analytics Division, Medical University of Lublin, Poland Author
  • Dariusz Matosiuk Chair and Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modeling Unit, Faculty of Pharmacy with Medical Analytics Division, Medical University of Lublin, Poland Author

DOI:

https://doi.org/10.12923/j.2084-980X/25.4/a.24

Keywords:

1-(2-pirydyl)-2-aminoimidazoline-2, phenyl isocyanate, 3-chlorphenyl iso-cyanate, benzyl isocyanate, phenethyl isocyanate

Abstract

The synthesis and physicochemical properties of new 1-[1-(2-pirydyl)imidazoline-2-ylidene]-3-aryl(arylalkyl)ureas [I-VIII]. The title compounds were obtained by condensation of 1-(2-pirydyl)-2-aminoimidazoline-2 with aryl isocyanate or arylalkyl isocyanate in dichloromethane under the atmosphere of dry nitrogen. The reaction was conducted in the room temperature for 24 h. Considering the structure of obtained compounds it can be expected that these compounds can reveal pharmacological activity.

References

1. Matosiuk D., Tkaczyński T., Stefańczyk J. :Synthesis and CNS activity of new 1-alkyl-2-aryl-7-hydryxy5(1H)oxo-imidzo[1,2-a]pyrimidines. Acta Pol. Pharm. 53, 209, 1996.

2. Matosiuk D., Fidecka S., Antkiewicz-Michaluk L., Dybała I., Kozioł A.E.: Synthesis and pharmacological activity of new carbonyl derivatives of 1-aryl-2-iminoimidazoline.Part 1. Eur. J. Med. Chem. 36, 783, 2001.

3. Matosiuk D., Fidecka S., Antkiewicz-Michaluk L., Dybała I., Kozioł A.E.: Synthesis and pharmacological activity of new carbonyl derivatives of 1-aryl-2-iminoimidazoline.Part 2. Eur. J. Med. Chem. 37, 761 2002.

4. Onioria J.M., Bufi L.L., Torrisi C. et al.: Identyfication of a series of 4-[3-(quinolin-2-yl)-1,2,4-oxadiazol-5-yl]piperazinyl ureas as potent smoothened antagonist hedgehog pathway inhibitors. Bioorganic and Medicinal Chemistry Letters 21(18), 5274, 2011

5. Perveen S., Fatima N., Khan M.A. et al.: Antidepressant activity of carbamates and urea derivatives. :Medicinal Chemistry Research 10 (17), 7, 2011

6. Szacon E., Rządkowska M., Stefańczyk J., Matosiuk D., Kędzierska E., Fidecka S.: Nowe pochodne 1-(2-pirydylo)-2-aminoimidazoliny oraz 1-[1-(2-pirydylo)imidazolin-2-yl]-3-podstawione pochodne mocznika i sposób ich wytwarzania.: Biuletyn UP 17, 9, 2010

7. Taie R.H., Rodge A.H., Hainapure G.D., Keche A.P.: The novel 3,4-dihydropyrimidin-2(1H)-one urea derivatives of N-aryl urea.: Bioorganic and Medicinal Chemistry Letters 15 (21), 4648, 2011

8. Wiliams M., Kowaluk E.A., Americ S.P., J. Med. Chem. 42, 148, 1999.

Downloads

Published

2012-12-28

How to Cite

Szacoń, E., Rządkowska, M., & Matosiuk, D. (2012). Synthesis of new derivatives of 1-[1-(2-pyridyl)-imidazolidine-2-ylidene]-3-aryl(arylakyl)ureas. Current Issues in Pharmacy and Medical Sciences, 25(4), 449-451. https://doi.org/10.12923/j.2084-980X/25.4/a.24